{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T11:46:50Z","timestamp":1770810410505,"version":"3.50.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008358","name":"Hersenstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008358","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rijnstate Vriendenfonds"},{"DOI":"10.13039\/100008894","name":"Stryker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008894","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020501","name":"Penumbra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09426-8","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:55:04Z","timestamp":1768542904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MR GENTLE\u2014multicentre randomised controlled trial of ghrelin in anterior circulation ischaemic stroke treated with endovascular thrombectomy: a phase 2 trial"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-6663","authenticated-orcid":false,"given":"Quinty P. M.","family":"Omes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens J. B. A.","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate M.","family":"Arntz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Margreet G.","family":"Filius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido R.","family":"van den Wijngaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Bart","family":"van der Worp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Hofmeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"8","key":"9426_CR1","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart disease and stroke statistics\u20142023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93-621.","journal-title":"Circulation"},{"issue":"9976","key":"9426_CR2","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/S0140-6736(15)60715-2","volume":"385","author":"M Brunstr\u00f6m","year":"2015","unstructured":"Brunstr\u00f6m M, Carlberg B. Thrombolysis in acute stroke. Lancet. 2015;385(9976):1394\u20135.","journal-title":"Lancet"},{"issue":"20 Suppl 2","key":"9426_CR3","first-page":"S6","volume":"97","author":"V Saini","year":"2021","unstructured":"Saini V, Guada L, Yavagal DR. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021;97(20 Suppl 2):S6-s16.","journal-title":"Neurology"},{"issue":"1","key":"9426_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1054\/jocn.2001.1027","volume":"9","author":"FJ Vajda","year":"2002","unstructured":"Vajda FJ. Neuroprotection and neurodegenerative disease. J Clin Neurosci. 2002;9(1):4\u20138.","journal-title":"J Clin Neurosci"},{"issue":"2","key":"9426_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5716","volume":"49","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhang X, Chen X, Wei Y. Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment (review). Int J Mol Med. 2022;49(2):1\u20139.","journal-title":"Int J Mol Med"},{"issue":"2","key":"9426_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/STROKEAHA.111.632943","volume":"43","author":"J Hofmeijer","year":"2012","unstructured":"Hofmeijer J, van Putten MJ. Ischemic cerebral damage: an appraisal of synaptic failure. Stroke. 2012;43(2):607\u201315.","journal-title":"Stroke"},{"issue":"Pt B","key":"9426_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuropharm.2017.11.050","volume":"134","author":"D Mayor","year":"2018","unstructured":"Mayor D, Tymianski M. Neurotransmitters in the mediation of cerebral ischemic injury. Neuropharmacology. 2018;134(Pt B):178\u201388.","journal-title":"Neuropharmacology"},{"issue":"3","key":"9426_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S1474-4422(07)70055-8","volume":"6","author":"JM Simard","year":"2007","unstructured":"Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6(3):258\u201368.","journal-title":"Lancet Neurol"},{"issue":"10","key":"9426_CR9","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.3390\/ijms23105381","volume":"23","author":"M Haupt","year":"2022","unstructured":"Haupt M, Gerner ST, B\u00e4hr M, Doeppner TR. Quest for quality in translational stroke research\u2014a new dawn for neuroprotection? Int J Mol Sci. 2022;23(10):5381.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9426_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ana.20741","volume":"59","author":"VE O\u2019Collins","year":"2006","unstructured":"O\u2019Collins VE, Macleod MR, Donnan GA, Horky LL, Van Der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Ann Neurol. 2006;59(3):467\u201377.","journal-title":"Ann Neurol"},{"issue":"12","key":"9426_CR11","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1161\/STROKEAHA.117.017283","volume":"48","author":"SI Savitz","year":"2017","unstructured":"Savitz SI, Baron J-C, Yenari MA, Sanossian N, Fisher M. Reconsidering neuroprotection in the reperfusion era. Stroke. 2017;48(12):3413\u20139.","journal-title":"Stroke"},{"issue":"6","key":"9426_CR12","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1161\/STROKEAHA.117.017040","volume":"48","author":"M Tymianski","year":"2017","unstructured":"Tymianski M. Combining neuroprotection with endovascular treatment of acute stroke. Stroke. 2017;48(6):1700\u20135.","journal-title":"Stroke"},{"key":"9426_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00249","volume":"9","author":"XY Xiong","year":"2018","unstructured":"Xiong XY, Liu L, Yang QW. Refocusing neuroprotection in cerebral reperfusion era: new challenges and strategies. Front Neurol. 2018;9:249.","journal-title":"Front Neurol"},{"issue":"4","key":"9426_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41582-021-00605-6","volume":"18","author":"M Fisher","year":"2022","unstructured":"Fisher M, Savitz SI. Pharmacological brain cytoprotection in acute ischaemic stroke \u2014 renewed hope in the reperfusion era. Nat Rev Neurol. 2022;18(4):193\u2013202.","journal-title":"Nat Rev Neurol"},{"key":"9426_CR15","doi-asserted-by":"publisher","first-page":"840892","DOI":"10.3389\/fneur.2022.840892","volume":"13","author":"EM Vos","year":"2022","unstructured":"Vos EM, Geraedts VJ, van der Lugt A, Dippel DWJ, Wermer MJH, Hofmeijer J, et al. Systematic review - combining neuroprotection with reperfusion in acute ischemic stroke. Front Neurol. 2022;13:840892.","journal-title":"Front Neurol"},{"issue":"2","key":"9426_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1152\/physrev.00012.2004","volume":"85","author":"M Kojima","year":"2005","unstructured":"Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85(2):495\u2013522.","journal-title":"Physiol Rev"},{"key":"9426_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neubiorev.2016.12.010","volume":"73","author":"Q Jiao","year":"2017","unstructured":"Jiao Q, Du X, Li Y, Gong B, Shi L, Tang T, et al. The neurological effects of ghrelin in brain diseases: beyond metabolic functions. Neurosci Biobehav Rev. 2017;73:98\u2013111.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"9426_CR18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cne.20823","volume":"494","author":"JM Zigman","year":"2006","unstructured":"Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol. 2006;494(3):528\u201348.","journal-title":"J Comp Neurol"},{"issue":"1","key":"9426_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1471-2202-15-49","volume":"15","author":"II Stoyanova","year":"2014","unstructured":"Stoyanova II, Le Feber J. Ghrelin accelerates synapse formation and activity development in cultured cortical networks. BMC Neurosci. 2014;15(1):49.","journal-title":"BMC Neurosci"},{"issue":"9","key":"9426_CR20","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1007\/s12035-015-9502-x","volume":"53","author":"II Stoyanova","year":"2016","unstructured":"Stoyanova II, Hofmeijer J, van Putten M, le Feber J. Acyl ghrelin improves synapse recovery in an in vitro model of postanoxic encephalopathy. Mol Neurobiol. 2016;53(9):6136\u201343.","journal-title":"Mol Neurobiol"},{"key":"9426_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.595914","volume":"9","author":"I Stoyanova","year":"2021","unstructured":"Stoyanova I, Lutz D. Ghrelin-mediated regeneration and plasticity after nervous system injury. Front Cell Dev Biol. 2021;9:595914.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"9426_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tins.2010.10.001","volume":"34","author":"ZB Andrews","year":"2011","unstructured":"Andrews ZB. The extra-hypothalamic actions of ghrelin on neuronal function. Trends Neurosci. 2011;34(1):31\u201340.","journal-title":"Trends Neurosci"},{"issue":"8","key":"9426_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/nure.12045","volume":"71","author":"B Beck","year":"2013","unstructured":"Beck B, Pouri\u00e9 G. Ghrelin, neuropeptide Y, and other feeding-regulatory peptides active in the hippocampus: role in learning and memory. Nutr Rev. 2013;71(8):541\u201361.","journal-title":"Nutr Rev"},{"issue":"38","key":"9426_CR24","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.2174\/13816128113199990411","volume":"19","author":"VV Dos Santos","year":"2013","unstructured":"Dos Santos VV, Rodrigues AL, De Lima TC, de Barioglio SR, Raisman-Vozari R, Prediger RD. Ghrelin as a neuroprotective and palliative agent in Alzheimer\u2019s and Parkinson\u2019s disease. Curr Pharm Des. 2013;19(38):6773\u201390.","journal-title":"Curr Pharm Des"},{"issue":"11","key":"9426_CR25","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.peptides.2011.09.019","volume":"32","author":"MD Gahete","year":"2011","unstructured":"Gahete MD, C\u00f3rdoba-Chac\u00f3n J, Kineman RD, Luque RM, Casta\u00f1o JP. Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer\u2019s disease. Peptides. 2011;32(11):2225\u20138.","journal-title":"Peptides"},{"issue":"3","key":"9426_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/SHK.0b013e3181f48a37","volume":"35","author":"C Cheyuo","year":"2011","unstructured":"Cheyuo C, Wu R, Zhou M, Jacob A, Coppa G, Wang P. Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock. 2011;35(3):258\u201365.","journal-title":"Shock"},{"issue":"1","key":"9426_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1210\/en.2006-0991","volume":"148","author":"H Chung","year":"2007","unstructured":"Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, et al. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology. 2007;148(1):148\u201359.","journal-title":"Endocrinology"},{"issue":"17","key":"9426_CR28","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1042\/CS20160077","volume":"130","author":"JM Ku","year":"2016","unstructured":"Ku JM, Taher M, Chin KY, Barsby T, Austin V, Wong CH, et al. Protective actions of des-acylated ghrelin on brain injury and blood-brain barrier disruption after stroke in mice. Clin Sci (Lond). 2016;130(17):1545\u201358.","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"9426_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.bbrc.2007.05.192","volume":"359","author":"Y Miao","year":"2007","unstructured":"Miao Y, Xia Q, Hou Z, Zheng Y, Pan H, Zhu S. Ghrelin protects cortical neuron against focal ischemia\/reperfusion in rats. Biochem Biophys Res Commun. 2007;359(3):795\u2013800.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"9426_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/brainsci3010344","volume":"3","author":"S Spencer","year":"2013","unstructured":"Spencer S, Miller A, Andrews Z. The role of ghrelin in neuroprotection after ischemic brain injury. Brain Sci. 2013;3(4):344\u201359.","journal-title":"Brain Sci"},{"issue":"3","key":"9426_CR31","doi-asserted-by":"publisher","DOI":"10.1088\/1741-2552\/abe68a","volume":"18","author":"S Pires Monteiro","year":"2021","unstructured":"Pires Monteiro S, Voogd E, Muzzi L, De Vecchis G, Mossink B, Levers M, et al. Neuroprotective effect of hypoxic preconditioning and neuronal activation in a in vitro human model of the ischemic penumbra. J Neural Eng. 2021;18(3):036016.","journal-title":"J Neural Eng"},{"issue":"5","key":"9426_CR32","first-page":"244","volume":"49","author":"Y Liu","year":"2006","unstructured":"Liu Y, Wang PS, Xie D, Liu K, Chen L. Ghrelin reduces injury of hippocampal neurons in a rat model of cerebral ischemia\/reperfusion. Chin J Physiol. 2006;49(5):244\u201350.","journal-title":"Chin J Physiol"},{"issue":"5","key":"9426_CR33","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/SHK.0000000000000337","volume":"43","author":"X Xie","year":"2015","unstructured":"Xie X, Zhang J, Chen D, Pan H, Wu Z, Ge D, et al. Effects of ghrelin on postresuscitation brain injury in a rat model of cardiac arrest. Shock. 2015;43(5):490\u20136.","journal-title":"Shock"},{"issue":"9","key":"9426_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2020;19(9):609\u201333.","journal-title":"Nat Rev Drug Discov"},{"key":"9426_CR35","doi-asserted-by":"crossref","unstructured":"Stoyanova, II. Ghrelin: a link between ageing, metabolism and neurodegenerative disorders. Neurobiol Dis. 2014;72 Pt A:72\u201383.","DOI":"10.1016\/j.nbd.2014.08.026"},{"issue":"5","key":"9426_CR36","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1210\/jc.2012-4247","volume":"98","author":"MC Garin","year":"2013","unstructured":"Garin MC, Burns CM, Kaul S, Cappola AR. Clinical review: the human experience with ghrelin administration. J Clin Endocrinol Metab. 2013;98(5):1826\u201337.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9426_CR37","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1053\/j.gastro.2009.12.058","volume":"138","author":"S Adachi","year":"2010","unstructured":"Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 2010;138(4):1312\u201320.","journal-title":"Gastroenterology"},{"issue":"4","key":"9426_CR38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s10147-011-0289-0","volume":"17","author":"Y Hiura","year":"2012","unstructured":"Hiura Y, Takiguchi S, Yamamoto K, Kurokawa Y, Yamasaki M, Nakajima K, et al. Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients. Int J Clin Oncol. 2012;17(4):316\u201323.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"9426_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/HYPERTENSIONAHA.111.171025","volume":"58","author":"E Lambert","year":"2011","unstructured":"Lambert E, Lambert G, Ika-Sari C, Dawood T, Lee K, Chopra R, et al. Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension. 2011;58(1):43\u201350.","journal-title":"Hypertension"},{"issue":"6","key":"9426_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamaneurol.2024.1088","volume":"81","author":"S Nutma","year":"2024","unstructured":"Nutma S, Beishuizen A, van den Bergh WM, Foudraine NA, le Feber J, Filius PMG, et al. Ghrelin for neuroprotection in post-cardiac arrest coma: a randomized clinical trial. JAMA Neurol. 2024;81(6):603\u201310.","journal-title":"JAMA Neurol"},{"issue":"1","key":"9426_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/STROKEAHA.119.026791","volume":"51","author":"V Chalos","year":"2020","unstructured":"Chalos V, Van Der Ende NAM, Lingsma HF, Mulder MJHL, Venema E, Dijkland SA, et al. National Institutes of Health Stroke Scale. Stroke. 2020;51(1):282\u201390.","journal-title":"Stroke"},{"issue":"8","key":"9426_CR42","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1161\/01.STR.30.8.1538","volume":"30","author":"G Sulter","year":"1999","unstructured":"Sulter G, Steen C, Jacques DK. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke. 1999;30(8):1538\u201341.","journal-title":"Stroke"},{"issue":"4","key":"9426_CR43","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1161\/STROKEAHA.114.007253","volume":"46","author":"A Wong","year":"2015","unstructured":"Wong A, Nyenhuis D, Black SE, Law LS, Lo ES, Kwan PW, et al. Montreal cognitive assessment 5-minute protocol is a brief, valid, reliable, and feasible cognitive screen for telephone administration. Stroke. 2015;46(4):1059\u201364.","journal-title":"Stroke"},{"issue":"4","key":"9426_CR44","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1161\/STROKEAHA.121.034859","volume":"53","author":"EA Mistry","year":"2022","unstructured":"Mistry EA, Yeatts SD, Khatri P, Mistry AM, Detry M, Viele K, et al. National institutes of health stroke scale as an outcome in stroke research: value of ANCOVA over analyzing change from baseline. Stroke. 2022;53(4):e150-5.","journal-title":"Stroke"},{"issue":"5","key":"9426_CR45","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC Van Swieten","year":"1988","unstructured":"Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604\u20137.","journal-title":"Stroke"},{"issue":"2","key":"9426_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000262309","volume":"29","author":"PM Janssen","year":"2010","unstructured":"Janssen PM, Visser NA, Dorhout Mees SM, Klijn CJ, Algra A, Rinkel GJ. Comparison of telephone and face-to-face assessment of the modified Rankin Scale. Cerebrovasc Dis. 2010;29(2):137\u20139.","journal-title":"Cerebrovasc Dis"},{"issue":"8","key":"9426_CR47","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00415-007-0646-0","volume":"254","author":"M Uyttenboogaart","year":"2007","unstructured":"Uyttenboogaart M, Luijckx GJ, Vroomen PC, Stewart RE, De Keyser J. Measuring disability in stroke: relationship between the modified Rankin scale and the Barthel index. J Neurol. 2007;254(8):1113\u20137.","journal-title":"J Neurol"},{"issue":"7","key":"9426_CR48","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1161\/STROKEAHA.111.613521","volume":"42","author":"GL Della Pietra","year":"2011","unstructured":"Della Pietra GL, Savio K, Oddone E, Reggiani M, Monaco F, Leone MA. Validity and reliability of the Barthel index administered by telephone. Stroke. 2011;42(7):2077\u20139.","journal-title":"Stroke"},{"issue":"1","key":"9426_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/STROKEAHA.112.673384","volume":"44","author":"ST Pendlebury","year":"2013","unstructured":"Pendlebury ST, Welch SJV, Cuthbertson FC, Mariz J, Mehta Z, Rothwell PM. Telephone assessment of cognition after transient ischemic attack and stroke. Stroke. 2013;44(1):227\u20139.","journal-title":"Stroke"},{"issue":"1","key":"9426_CR50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials \u2013 a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162.","journal-title":"BMC Med Res Methodol"},{"key":"9426_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.614698","volume":"12","author":"S Nutma","year":"2021","unstructured":"Nutma S, le Feber J, Hofmeijer J. Neuroprotective treatment of postanoxic encephalopathy: a review of clinical evidence. Front Neurol. 2021;12:614698.","journal-title":"Front Neurol"},{"issue":"2","key":"9426_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147231","volume":"11","author":"J Le Feber","year":"2016","unstructured":"Le Feber J, Tzafi Pavlidou S, Erkamp N, Van Putten MJAM, Hofmeijer J. Progression of neuronal damage in an in vitro model of the ischemic penumbra. PLoS One. 2016;11(2):e0147231.","journal-title":"PLoS One"},{"issue":"2","key":"9426_CR53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1212\/WNL.0000000000001742","volume":"85","author":"J Hofmeijer","year":"2015","unstructured":"Hofmeijer J, Beernink TM, Bosch FH, Beishuizen A, Tjepkema-Cloostermans MC, van Putten MJ. Early EEG contributes to multimodal outcome prediction of postanoxic coma. Neurology. 2015;85(2):137\u201343.","journal-title":"Neurology"},{"issue":"1","key":"9426_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/CCM.0000000000000626","volume":"43","author":"MC Tjepkema-Cloostermans","year":"2015","unstructured":"Tjepkema-Cloostermans MC, Hofmeijer J, Trof RJ, Blans MJ, Beishuizen A, van Putten MJ. Electroencephalogram predicts outcome in patients with postanoxic coma during mild therapeutic hypothermia. Crit Care Med. 2015;43(1):159\u201367.","journal-title":"Crit Care Med"},{"key":"9426_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroscience.2013.10.063","volume":"257","author":"Z Zhao","year":"2014","unstructured":"Zhao Z, Liu H, Xiao K, Yu M, Cui L, Zhu Q, et al. Ghrelin administration enhances neurogenesis but impairs spatial learning and memory in adult mice. Neuroscience. 2014;257:175\u201385.","journal-title":"Neuroscience"},{"key":"9426_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2019.170226","volume":"124","author":"K Raghay","year":"2020","unstructured":"Raghay K, Akki R, Bensaid D, Errami M. Ghrelin as an anti-inflammatory and protective agent in ischemia\/reperfusion injury. Peptides. 2020;124:170226.","journal-title":"Peptides"},{"issue":"5","key":"9426_CR57","doi-asserted-by":"publisher","first-page":"R1483","DOI":"10.1152\/ajpregu.2001.280.5.R1483","volume":"280","author":"N Nagaya","year":"2001","unstructured":"Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol. 2001;280(5):R1483\u20137.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4","key":"9426_CR58","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1530\/eje.0.1500447","volume":"150","author":"T Akamizu","year":"2004","unstructured":"Akamizu T, Takaya K, Irako T, Hosoda H, Teramukai S, Matsuyama A, et al. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol. 2004;150(4):447\u201355.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"9426_CR59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22(9):391\u20137.","journal-title":"Trends Neurosci"},{"issue":"10","key":"9426_CR60","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1161\/STROKEAHA.109.557256","volume":"40","author":"TJ Quinn","year":"2009","unstructured":"Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified rankin scale. Stroke. 2009;40(10):3393\u20135.","journal-title":"Stroke"},{"key":"9426_CR61","doi-asserted-by":"crossref","unstructured":"Quinn T, Harrison, McArthur. Assessment scales in stroke: clinimetric and clinical considerations. Clinical Interventions in Aging. 2013:201.","DOI":"10.2147\/CIA.S32405"},{"issue":"7","key":"9426_CR62","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S1474-4422(06)70495-1","volume":"5","author":"SE Kasner","year":"2006","unstructured":"Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol. 2006;5(7):603\u201312.","journal-title":"Lancet Neurol"},{"issue":"7","key":"9426_CR63","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","volume":"20","author":"T Brott","year":"1989","unstructured":"Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864\u201370.","journal-title":"Stroke"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09426-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09426-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09426-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:06:23Z","timestamp":1770771983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09426-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9426"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09426-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is approved by local ethical committee (METC Oost-Nederland, with number NL81487.091.22) and by the competent authorities of the Netherlands (CCMO). The trial is prospectively registered on ClinicalTrials.gov (NCT05726240;\n                      \n                      ) on 25th of July, 2023, and received the EudraCT number 2022\u2013001632-28. Since October 14, 2024, the trial is also registered through CTIS according to the European Trial Regulation (number 2024\u2013515705-26\u201300). The study will be conducted according to the principles of the Declaration of Helsinki (7th revision, Fortaleza, 2013) and in accordance with the Dutch Medical Research Involving Human Subjects Act (WMO) and local guidelines. Data will be collected and processed in accordance with the General Data Protection Regulation (EU) 2016\/679.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"126"}}